Mounjaro®
Starting from £179.99/mo
Start journey Learn moreIf you take tirzepatide or semaglutide and want to give blood, you may have heard that it rules you out entirely. That is not quite right. Whether you can donate depends on which medicine you take, the donation centre's current policy, and a short deferral period — not a blanket ban. These are prescription-only medicines that require clinical assessment before anyone is prescribed them, so the answer deserves a careful look rather than a quick one.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
This is the misconception our prescribers hear most weeks when patients ask about donating blood. The reality is more nuanced. UK blood services apply deferral periods rather than lifetime exclusions for most medicines. A deferral period means you wait a set time after stopping (or sometimes after starting) treatment before your donation is accepted. It is a standard precautionary step that applies to dozens of prescription medicines, not a judgment on whether your blood is safe.
Tirzepatide and semaglutide are both relatively recent additions to the UK formulary, and blood services update their deferral lists as post-marketing safety data accumulates. NHS Blood and Transplant reviews these policies regularly. The practical upshot is that the rules can change, and the only reliable source is NHSBT itself, not a third-party article written months ago. If giving blood matters to you, check with NHS Blood and Transplant directly, their helpline and website hold the current policy for each medicine by name.
If you are curious about how these medicines interact with other aspects of your health, the overview on weight loss injections covers the broader clinical picture.
For medicines under active post-market surveillance (which both Mounjaro and Wegovy are, as both carry the Black Triangle (▼) designation) UK blood services have typically applied a deferral of at least one year after stopping treatment before a donation is accepted. Some centres defer for the entire duration of treatment too, meaning donations are paused while you are actively taking the medicine.
That one-year figure is a guide, not a guarantee. Policies differ between England, Scotland, Wales and Northern Ireland because donation services are separately administered. The Scottish National Blood Transfusion Service may hold a different position from NHSBT. If you are in Scotland, check with the SNBTS directly, or see the NHS Inform guidance on diabetes and weight loss medicines for clinical context on these treatments.
It is also worth knowing that a dose increase or a restart after a break may reset the deferral clock. So if you paused treatment, waited, and then resumed, the countdown starts again. This is another reason to telephone the donation centre before you book a session, the answer you got six months ago may no longer apply.
Patients on weight-loss injections often have questions about their blood beyond donation. If you also take anticoagulants or blood-thinning medicines, the considerations are different again, you can read more in our page on taking weight loss injections alongside blood thinners. Similarly, if high blood pressure is part of your picture, our clinicians often address how treatment interacts with that in the weight loss injections and high blood pressure guide.
There is also a separate question (addressed by some readers who arrive here) about whether these medicines carry a risk related to clotting. The evidence on that is discussed in the guide on blood clots and weight loss injections. These are distinct concerns from donation policy, and conflating them can cause unnecessary worry.
For pricing context if you are considering starting treatment, the cost of weight loss injections guide explains how private pricing works in the UK and what a legitimate prescription service includes, useful background before you make any decisions.
If you have not yet started a weight-loss injection and giving blood is something you do regularly, it is sensible to factor this in before beginning. Ask your prescriber at the point of consultation, or raise it with the donation centre first so you know where you stand. That way you can plan around any deferral period rather than being caught out after you have already started treatment.
If you are already taking tirzepatide or semaglutide and want to donate, the steps are straightforward. Contact NHSBT or your local donation centre, name the medicine precisely, and ask for their current deferral policy. Do not assume the position has not changed since you last checked. The NHS tirzepatide patient information page at nhs.uk/medicines/tirzepatide is a useful reference for how the medicine is classified, though donation policy itself sits with the blood services.
If you are thinking about starting weight-loss treatment and want to understand how long you might be on it, the guide on how long you can take weight loss injections covers the evidence on treatment duration. And if you would like to talk through your personal situation with a prescriber, you can start that conversation at nume's free consultation, reviewed the same day by a real clinician, not a queue.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.